Skip to main content
PPN WorldPPN World

PPN World · Archive

Reserved for subscribers

This release sits in the PPN World archive. Subscribers read the full wire as it lands — 80+ newswires, 190+ countries, searchable back through the archive, with alerts on the subjects they track.

  • Every release, the moment it crosses — not a daily digest
  • Search and filter the full archive, not the last 24 hours
  • Instant alerts on saved searches

PPN World — real-time press release intelligence.

Bristol Myers Squibb Announces ZENBEXUS (iberdomide) in Combination with Daratumumab and Dexamethasone (ZDd) Demonstrates Superior Progression-Free Survival vs. Standard of Care in Relapsed and Refractory Multiple Myeloma in Phase 3... · Bristol Myers Squibb — Press Releases · PPN World